Wockhardt Fails To Nix Sepracor's Lunesta Patents
A federal judge has thrown out generic-drug maker Wockhardt Ltd.'s claim that Sepracor Inc. misled patent examiners by covering up rat study data related to sleep drug Lunesta, saying that the...To view the full article, register now.
Already a subscriber? Click here to view full article